Nessan Bermingham is the founder of Korro Bio. Korro Bio has raised $92M in total funding. Latest round: Series A. Based in Cambridge, USA.
Nessan Bermingham co-founded Korro Bio, a Cambridge, Massachusetts-based biotechnology company focused on RNA editing, in 2018. He established the company after previously directing Intellia Therapeutics Inc. Korro Bio was incubated at Atlas Venture and launched with initial funding from Atlas Venture and New Enterprise Associates.
Full founder directory · Investor directory · Company funding database · Fundraising library